K

    Kestra Medical Technologies, Ltd. Common Stock (KMTS)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $25.75
    +0.11 (+0.43%)

    Market Cap: $1.51B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(3/6)
    Avg Surprise
    -15.17%

    Upcoming Estimates

    Period ending Jul 31, 2026
    EPS Consensus$-0.63
    Range$-0.63 - $-0.62
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$-0.54+13.6%
    60d ago$-0.54+13.6%
    30d ago$-0.54+13.6%
    7d ago$-0.63+0.0%
    Current$-0.63
    Revenue Consensus
    $29M
    Range$29M - $29M
    8 analysts
    Period ending Oct 31, 2026
    EPS Consensus$-0.61
    Range$-0.62 - $-0.61
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$-0.55+11.4%
    60d ago$-0.55+11.4%
    30d ago$-0.55+11.4%
    7d ago$-0.61+0.0%
    Current$-0.61
    Revenue Consensus
    $32M
    Range$31M - $32M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Oct 26EST
    		-$-0.61---
    Jul 26EST
    		-$-0.63---
    Apr 26
    Reported Jul 14
    		$-0.67$-0.59-13.56%Miss+36.8%
    Jan 26
    Reported Mar 17
    		$-0.40$-0.60+33.33%Beat+66.1%
    Oct 25
    Reported Dec 11
    		$-0.45$-0.56+19.64%Beat-
    Jul 25
    Reported Sep 11
    		$-0.36N/A+53.85%Beat-
    Apr 25
    Reported Jul 17
    		$-1.06$-0.53-99.91%Miss-
    Jan 25
    Reported Apr 14
    		$-1.18$-0.64-84.38%Miss-

    Key Metrics

    Valuation
    P/E Ratio-13.70EV/EBITDAN/A
    Price/FCF-12.33xFCF Yield-8.11%
    Profitability
    Profit Margin-138.30%Operating Margin-137.40%
    ROE-56.60%ROIC-41.90%
    Financial Health
    Debt/Equity0.15xInterest Coverage-18.55x
    Current Ratio7.32xQuick Ratio7.16x
    Trading Statistics
    BetaN/AAvg Volume290.92K
    52-Week High$30.0052-Week Low$15.82

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$26.77
    SMA 20$26.91
    SMA 50$25.21
    SMA 200$23.59
    EMA 10$26.43
    EMA 20$26.29
    EMA 50$25.08
    EMA 200$23.32

    MACD

    Line: 0.41Signal: 0.75Hist: -0.34

    ADX

    ADX: 15.1+DI: 17.3-DI: 21.1

    Aroon & PSAR

    Aroon Up68.0
    Aroon DownN/A
    PSAR$27.99

    Bollinger Bands

    Upper Band$29.00
    Lower Band$24.82
    %B Position1554%(Upper)
    Band Width0.22

    RSI (14-Day)

    Neutral
    48.0

    Momentum Oscillators

    Stoch %K7.8
    Stoch %D18.3
    Williams %R-82.0
    ROC (10d)-7.4%
    Momentum-2.07
    CCI (20d)-94.4
    MFI (14d)23.7

    Volatility Measures

    ATR (14d)$1.30(5.1%)
    StdDev (20d)1.05
    Hist Vol47.6%(High)

    Volume Flow

    VWAP$25.57
    OBV7.4M
    AD Line3.0M
    CMF (20d)0.155

    Volume Metrics

    Avg Vol (20d)286.8K
    Vol Ratio1.2x
    VWMA (20d)$26.87

    Pivot Points

    R3$26.91
    R2$26.60
    R1$26.12
    Pivot Point$25.80
    S1$25.32
    S2$25.01
    S3$24.53

    Advanced Oscillators

    TSI10.25
    Ultimate Osc46.4
    KST98.84

    Financial Data

    QuarterJan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023Jul 2023Jul 2021
    Total Revenue$24.55M$22.57M$19.37M$17.23M$15.09M$22.57M$19.37M$10.05M$8.28M$14.71M$12.78MN/A
    Cost of Revenue$11.65M$11.14M$10.52M$9.60M$8.54M$11.14M$10.52M$8.66M$7.40M$8.88M$8.58MN/A
    Gross Profit$12.91M$11.42M$8.85M$7.63M$6.55M$11.42M$8.85M$1.40M$880,000$5.83M$4.20MN/A
    Operating Expenses$47.67M$43.18M$37.73M$55.84M$27.15M$43.18M$37.73M$21.75M$20.83M$24.96M$22.63M$12.29M
    R&D$4.97M$4.88M$4.00M$5.39M$3.35M$4.88M$4.00M$3.82M$3.73M$3.51M$3.40M$4.86M
    SG&A$42.70M$38.30M$33.73M$50.46M$23.80M$38.30M$33.73M$17.93M$17.09M$21.45M$19.23M$0
    Operating Income$-34,765,000$-31,755,000$-28,878,000$-48,212,000$-20,601,000$-31,755,000$-28,878,000$-20,349,000$-19,946,000$-19,134,000$-18,431,000$-12,290,000
    Interest Income$2.16M$1.80M$2.17M$1.66M$628,000$1.80M$2.17M$0$0$878,000$37,000$0
    Interest Expense$1.89M$1.90M$1.91M$1.76M$1.78M$1.90M$1.91M$1.94M$1.65M$2.32M$1.87M$847,000
    Income Before Tax$-34,131,000$-32,751,000$-25,793,000$-51,009,000$-21,741,000$-32,751,000$-25,793,000$-22,311,000$-21,605,000$-20,613,000$-20,316,000$-13,077,000
    Income Tax Expense$35,000$34,000$33,000$102,000$18,000$34,000$33,000$-27,000$14,000$8,000$7,000$57,000
    Net Income$-34,166,000$-32,785,000$-25,826,000$-52,053,000$-21,509,000$-32,785,000$-25,826,000$-22,284,000$-21,619,000$-20,368,000$-19,884,000$-13,134,000
    EBITDA$-34,406,000$-28,477,000$-21,853,000$-47,413,000$-18,761,000$-29,805,000$-23,551,000$-16,874,000$-19,954,000$-16,644,000$-15,904,000$-12,155,000
    EBIT$-34,406,000$-30,850,000$-23,881,000$-49,249,000$-20,586,000$-32,646,000$-26,048,000$-20,376,000$-19,954,000$-19,174,000$-18,479,000$-12,230,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about KMTS

    News

    Kestra Medical Technologies, Ltd. Announces Appointment of Curtis Kopf to Senior Vice President of Customer Experience

    Kestra Medical Technologies, Ltd. has appointed Curtis Kopf as their new Senior Vice President of Customer Experience. In this role, Mr. Kopf will be responsible for overseeing the entire patient experience, from order approval to therapy completion and device return, for the ASSURE WCD. He brings extensive experience from previous leadership positions at Insulet Corporation and REI, where he focused on customer experience, digital transformation, and large-scale service operations.

    www.marketscreener.com•8/26/26•
    Bullish

    Price to book forward of Kestra Medical Technologies, Ltd. – NASDAQ:KMTS

    This page displays financial data for Kestra Medical Technologies, Ltd. (KMTS) on the Nasdaq Stock Market, specifically focusing on its price-to-book forward ratio. The content indicates market status and provides links to various financial tools and community features offered by TradingView.

    TradingView•8/22/26•
    Neutral

    Price to sales forward of Kestra Medical Technologies, Ltd. – NASDAQ:KMTS

    The article discusses the forward price to sales ratio for Kestra Medical Technologies, Ltd. (NASDAQ: KMTS). It provides an overview of the company's financial data available on TradingView, noting that the market is currently closed with no trades. The content primarily lists various functionalities and disclaimers of the TradingView platform rather than detailed financial analysis of KMTS.

    TradingView•8/22/26•
    Neutral

    Price to earnings forward of Kestra Medical Technologies, Ltd. – BOATS:KMTS

    This page provides financial information for Kestra Medical Technologies, Ltd. (KMTS) on the Blue Ocean Alternative Trade System (BOATS), specifically focusing on its forward price-to-earnings ratio. The content appears to be a stub or an incomplete data entry, as no actual financial figures are presented. It primarily consists of navigation elements and copyright information from TradingView and its data providers.

    TradingView•8/21/26•
    Neutral

    Enterprise value to EBIT forward of Kestra Medical Technologies, Ltd. – NASDAQ:KMTS

    This article provides financial information for Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), specifically focusing on its enterprise value to EBIT forward. It indicates that the market was closed at the time of the data extraction, with no trades reported for the company. The content also briefly lists various financial tools and data providers associated with the TradingView platform.

    TradingView•8/20/26•
    Neutral

    Frequently Asked Questions About KMTS

    Does KMTS pay dividends?
    Kestra Medical Technologies, Ltd. Common Stock (KMTS) does not currently pay a regular dividend.
    What is KMTS's market cap?
    Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a market capitalization of $1.51B with a current stock price of $25.75.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In